Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

被引:93
|
作者
Tan, Sih Min [1 ]
Zhang, Yuan [1 ]
Connelly, Kim A. [1 ,3 ]
Gilbert, Richard E. [1 ,3 ]
Kelly, Darren J. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] St Vincents Inst Med Res, Melbourne, Vic, Australia
[3] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
基金
英国医学研究理事会;
关键词
interstitial fibrosis; cardiac remodeling; heart failure; SMOOTH MUSCLE ACTIN; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; FIBROSIS; TISSUE; INJURY; HEART; MYOFIBROBLASTS; HYPERTROPHY; TRANSITION;
D O I
10.1152/ajpheart.01048.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 298: H1415-H1425, 2010. First published February 12, 2010; doi:10.1152/ajpheart.01048.2009.-Following myocardial infarction (MI), the heart undergoes a pathological process known as remodeling, which in many instances results in cardiac dysfunction and ultimately heart failure and death. Transforming growth factor-beta (TGF-beta) is a key mediator in the pathogenesis of cardiac remodeling following MI. We thus aimed to inhibit TGF-beta signaling using a novel orally active TGF-beta type I receptor [activin receptor-like kinase 5 (ALK5)] inhibitor (GW788388) to attenuate left ventricular remodeling and cardiac dysfunction in a rat model of MI. Sprague-Dawley rats underwent left anterior descending coronary artery ligation to induce experimental MI and then were randomized to receive GW788388 at a dosage of 50 mg . kg(-1) . day(-1) or vehicle 1 wk after surgery. After 4 wk of treatment, echocardiography was performed before the rats were euthanized. Animals that received left anterior descending coronary artery ligation demonstrated systolic dysfunction, Smad2 activation, myofibroblasts accumulation, collagen deposition, and myocyte hypertrophy (all P < 0.05). Treatment with GW788388 significantly attenuated systolic dysfunction in the MI animals, together with the attenuation of the activated (phosphorylated) Smad2 (P < 0.01), alpha-smooth muscle actin (P < 0.001), and collagen I (P < 0.05) in the noninfarct zone of MI rats. Cardiomyocyte hypertrophy in MI hearts was also attenuated by ALK5 inhibition (P < 0.05). In brief, treatment with a novel TGF-beta type I receptor inhibitor, GW788388, significantly reduced TGF-beta activity, leading to the attenuation of systolic dysfunction and left ventricular remodeling in an experimental rat model of MI.
引用
收藏
页码:H1415 / H1425
页数:11
相关论文
共 50 条
  • [21] PHARMACOLOGIC INHIBITION OF ACTIVIN RECEPTOR-LIKE KINASES-5 BY SB 431542 ATTENUATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    Koh, Rhun Yian
    Uhal, Bruce D.
    Lim, Chooi Ling
    Abdullah, Maha
    Vidyadaran, Sharmili
    Ho, Coy Choke
    Seow, Heng Fong
    RESPIROLOGY, 2010, 15 : 83 - 83
  • [22] Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure
    Morine, Kevin J.
    Qiao, Xiaoying
    Paruchuri, Vikram
    Aronovitz, Mark J.
    Mackey, Emily E.
    Buiten, Lyanne
    Levine, Jonathan
    Ughreja, Keshan
    Nepali, Prerna
    Blanton, Robert M.
    Oh, S. Paul
    Karas, Richard H.
    Kapur, Navin K.
    CARDIOVASCULAR PATHOLOGY, 2017, 31 : 26 - 33
  • [23] Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction
    Soraya, Hamid
    Clanachan, Alexander S.
    Rameshrad, Maryam
    Maleki-Dizaji, Nasrin
    Ghazi-Khansari, Mahmoud
    Garjani, Alireza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 737 : 77 - 84
  • [24] Contribution of activin receptor-like kinase 5 (Transforming growth factor β receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts
    Chen, YL
    Xu, SW
    Eastwood, M
    Black, CM
    Denton, CP
    Leask, A
    Abraham, DJ
    ARTHRITIS AND RHEUMATISM, 2006, 54 (04): : 1309 - 1316
  • [25] Reduction of Activin Receptor-Like Kinase 4 Expression Ameliorates Myocardial Ischemia/Reperfusion Injury through Inhibiting TGFβ Signaling Pathway
    Chen, Mantian
    Sun, Yinggang
    Wang, Qian
    Li, Yigang
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [26] DPP-4 INHIBITION ATTENUATES CARDIAC DYSFUNCTION AND ADVERSE REMODELLING FOLLOWING MYOCARDIAL INFARCTION IN EXPERIMENTAL DIABETES
    Connelly, K. A.
    Desjardins, J.
    Advani, A.
    Kabir, G.
    Zhang, Y.
    Advani, S. L.
    Yuen, D. A.
    Thai, K.
    Gilbert, R. E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S328 - S328
  • [27] Activin Receptor-Like Kinase 5 Inhibition Reverses Impairment of Endothelial Cell Viability by Endogenous Islet Mesenchymal Stromal Cells
    Clarkin, Claire E.
    King, Aileen J.
    Dhadda, Paramjeet
    Chagastelles, Pedro
    Nardi, Nance
    Wheeler-Jones, Caroline P.
    Jones, Peter M.
    STEM CELLS, 2013, 31 (03) : 547 - 559
  • [28] Thermoreversible Gel for Delivery of Activin Receptor-Like Kinase 5 Inhibitor in Glaucoma Filtration Surgery
    Miladore, N.
    Nakamura, H.
    Geldenhuys, W.
    Bhatia, D.
    Sutariya, V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [29] The up-regulation of the activin receptor-like kinase5 in the subconjunctival wound healing
    Fu, Shuhao
    Xiao, Yiqin
    Ye, Wen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [30] Inhibition of Endogenous GSK-3β Attenuates Cardiac Dysfunction after Myocardial Infarction
    Zhai, Peiyong
    Galeotti, Jonathan
    Gao, Shumin
    Shao, Dan
    Sadoshima, Junichi
    CIRCULATION, 2008, 118 (18) : S351 - S351